Department of Health and Human Services October 24, 2024 – Federal Register Recent Federal Regulation Documents

Department of Health and Human Services Policy for the Protection of Human Research Subjects: Update to the Additional Protections for Specific Populations
Document Number: 2024-24399
Type: Rule
Date: 2024-10-24
Agency: Department of Health and Human Services
In this final rule, the Department of Health and Human Services (HHS) is amending its regulations that govern the protection of human subjects for conformity with 2018 revisions made to the Federal policy for protection of human research subjects (the "Common Rule"), as well as to maintain consistency with the prior version of the Common Rule for research that remains subject to those requirements. Amendments include updating citations that were renumbered, adding updated descriptions of the applicability of exemptions, and correcting a technical error. No substantive amendments are included in this final rule.
Submission for Office of Management and Budget Review; Legal and Advocacy Services for Unaccompanied Children (Office of Management and Budget #0970-0565)
Document Number: 2024-24588
Type: Notice
Date: 2024-10-24
Agency: Department of Health and Human Services, Administration for Children and Families
The Office of Refugee Resettlement (ORR), Administration for Children and Families (ACF), U.S. Department of Health and Human Services is inviting public comment on revisions to an approved information collection. The request consists of several forms that allow the Unaccompanied Children (UC) Program to provide legal and advocacy services to unaccompanied children.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food, and Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Animal Food
Document Number: 2024-24771
Type: Notice
Date: 2024-10-24
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2024-24745
Type: Notice
Date: 2024-10-24
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2024-24744
Type: Notice
Date: 2024-10-24
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
Document Number: 2024-24743
Type: Notice
Date: 2024-10-24
Agency: Department of Health and Human Services, National Institutes of Health
Designation of a Class of Employees for Addition to the Special Exposure Cohort
Document Number: 2024-24643
Type: Notice
Date: 2024-10-24
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
HHS gives notice of a decision to designate a class of employees from Metals and Controls Corp. in Attleboro, Massachusetts, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000.
Office of the Secretary; Notice of Meeting
Document Number: 2024-24642
Type: Notice
Date: 2024-10-24
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities; Proposed Collection; Comment Request; Antimicrobial Animal Drug Sales and Distribution
Document Number: 2024-24721
Type: Notice
Date: 2024-10-24
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of our reporting and recordkeeping requirements for antimicrobial animal drug sales and distribution.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adherence Potential and Patient Preference in Prescription Drug Promotion
Document Number: 2024-24720
Type: Notice
Date: 2024-10-24
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Food and Drug Administration Enforcement Policy for Association of American Feed Control Officials-Defined Animal Feed Ingredients; Guidance for Industry; Availability
Document Number: 2024-24715
Type: Rule
Date: 2024-10-24
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry #293 entitled "FDA Enforcement Policy for AAFCO-Defined Animal Feed Ingredients." This communicates FDA's enforcement policy regarding ingredients listed in chapter six of the 2024 Association of American Feed Control Officials (AAFCO) Official Publication after the Agency's memorandum of understanding with AAFCO expired on October 1, 2024.
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Document Number: 2024-24713
Type: Notice
Date: 2024-10-24
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The Committee will discuss Considerations for Respiratory Syncytial Virus (RSV) Vaccine Safety in Pediatric Populations and will also hear overviews of the Laboratory of Immunoregulation (LI) and Laboratory of Retroviruses (LR) research programs in the Center for Biologics Evaluation and Research. At least one portion of the meeting will be closed to the public. FDA is establishing a docket for public comment on this document.
HHS Approval of Entities That Certify Medical Review Officers
Document Number: 2024-24735
Type: Notice
Date: 2024-10-24
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This notice publishes a list of the Department of Health and Human Services (HHS) approved Medical Review Officers certification entities. The most recent HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), effective on October 10, 2023 (Oral Fluid) and February 1, 2024 (Urine), address the role and qualifications of Medical Review Officers (MROs) and HHS approval of entities that certify MROs.
Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Environmental Information and Documentation
Document Number: 2024-24732
Type: Notice
Date: 2024-10-24
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate below or any other aspect of the ICR.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.